JEENA SIKHO LIFECARE LTD

Jeena Sikho Lifecare Limited (JSLL) held its Q1 FY27 Earnings Conference Call on August 10, 2026, to discuss its financial results for the quarter ended June 30, 2026. Management highlighted a shift in healthcare focus from treatment to prevention, emphasizing their business model that integrates health awareness, consultations, and Ayurvedic treatments. For Q1 FY27, the company reported revenues of INR 224 crores, with an EBITDA of INR 92 crores and a PAT of INR 65 crores, reflecting a 29% year-on-year revenue growth. Management noted a strong performance in both Ayurveda healthcare services and products, with a 41% EBITDA margin. They outlined plans for technological integration in preventive healthcare and expressed a long-term vision of creating a comprehensive health operating system. The management reiterated their goal of achieving INR 3,000 crores in turnover and INR 1,000 crores in PAT over the next few years, emphasizing the importance of building a trust-based ecosystem in healthcare.

Management emphasized strong financial performance and a clear long-term vision for growth.